Sign in
Looking to the future: focus on DPP-4 inhibitors for the treatment of type 2 diabetes and emerging therapies
Journal article   Peer reviewed

Looking to the future: focus on DPP-4 inhibitors for the treatment of type 2 diabetes and emerging therapies

Joshua J Neumiller, Peggy Soule Odegard, John R White, Jr, Stephen M Setter and R Keith Campbell
The Diabetes educator, Vol.34(2), pp.183-200
03/2008
Handle:
https://hdl.handle.net/2376/110271
PMID: 18375772

Abstract

Hypoglycemic Agents - therapeutic use Triazoles - adverse effects Dipeptidyl-Peptidase IV Inhibitors - adverse effects Dipeptidyl-Peptidase IV Inhibitors - therapeutic use Humans Pyrazines - adverse effects Dipeptidyl Peptidase 4 Pyrazines - therapeutic use Sitagliptin Phosphate Diabetes Mellitus, Type 2 - drug therapy Triazoles - therapeutic use

Metrics

3 Record Views

Details